Zoetis

ZTS

Market cap $55.3B

Markets swing on AI angst and geopolitics, but high-ROE plays like Ross Stores could offer steady returns as investors hunt for cash-rich resilience.

Zoetis Inc. (ZTS) Presents at BofA Securities Animal Health Summit Transcript

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Securities 2026 Animal Health Summit on Thursday, February 26, 2026 at 1:15 p.m. ET. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company. Interested parties can access the live audio webcast by visiting https://investor.zoetis.com/events-presentations. A replay will also be available on the Zoetis website at the conclusion of the event. About Zoetis Zoet.

Healthcare is an evergreen industry ripe for finding fantastic dividend-growth stocks. The Wegovy pill has breathed new life into Novo Nordisk.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Eli Lilly is included due to its strategic positioning with respect to sustainability opportunities, specifically in HealthCare Access and Innovation. Advanced Micro Devices is owned for its exceptional Corporate Resilience profile and attractive sustainability opportunity set in areas like the Digital Infrastructure build-out. Oracle stands out with a strong sustainability profile, offering notable opportunities in Digital Infrastructure, Education and the development of Enhanced Skills & Innovation.

Zoetis is reiterated as a buy, with a 20% upside to a $159/share fair value, driven by margin expansion and a cheap valuation. ZTS delivered FY 2025 revenue of $9.5B, beating guidance, and presents expanding gross margins (83.5%) and shareholder-friendly share-count reduction via buybacks. International livestock and a robust pipeline (up to 12 blockbusters) provide secular growth tailwinds, offsetting US consumer retrenchment and competitive pressures.

Animal health firm Zoetis Inc.  (NYSE: ZTS) on Thursday reported a fourth-quarter 2025 adjusted earnings per share of $1.48. The company beat the consensus of $1.40.

Zoetis Inc. (ZTS) Q4 2025 Earnings Call Transcript